Crinetics Pharmaceuticals Inc.
CRNX | NASDAQ
$84.95
$0 (0.00%)
Sep 1, 2026, 9:30 AM ET · Market open
Institutional Ownership
Net InflowTotal Institutions
249
Total Ownership
117.94%
Capital Flow
+$738.41M
Shares Change
+11.16M
Ownership Distribution
Institutions (99.99%)
Others (0.01%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
47
Increased Positions
164
Reduced Positions
60
Closed Positions
51
New (47)
Increased (164)
Reduced (60)
Closed (51)
Options Sentiment & Activity
neutralPut/Call Ratio
1.051
Call Flow
65,000
Put Flow
68,300
Calls (49%)
Puts (51%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Fisher Asset Management LLC | 0.71% -2.77% | 0.02% | 741.55K | 62.99M | |
| Point72 Asset Management LP | 0.04% 0.00% | < 0.01% | 46.38K | 3.94M |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| FMR LLC | 15.14% -0.38% | 0.03% -11.13% | 15.76M +10.26% | 572.4M -13.97% | |
| Blackrock, Inc. | 8.14% -4.10% | < 0.01% -14.40% | 8.48M +6.14% | 307.95M -17.19% | |
| Farallon Capital Management LLC | 8.01% +8.66% | 1.73% +18.08% | 8.34M +20.27% | 302.84M -6.16% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove CRNX